Pfizer (PFE) Stock Offer, Spinoff Report Sees Fundamental Break-Up Post Zoetis (ZTS); Remember Bristol Myers & Mead Johnson? 400m shares are due to hit the market and today’s the last day for tendering Pfizer (PFE) common shares in exchange …
Reuters · 6/19/2013
Citigroup analyst, Andrew Baum, notified investors in a research note on Monday that it was increasing the price target on Pfizer Inc. (NYSE:PFE) stock from $36 to $37. The increase in price target follows the news regarding the pharmaceutical company’s ... · 2/9/2015
Shares of Allergan popped about 8 percent in early morning trade. Pfizer stock began to trade higher, before falling about 2 percent. Both stocks were initially halted immediately after the news. "Under any potential scenario with Pfizer, Allergan remains ...
CNBC · ByCatherine Boyle · 10/29/2015
Big pharma Pfizer (PFE) was down 2.5% in morning trading on the stock market today after its breast-cancer drug palbociclib did well in trials but fell a bit short of sky-high expectations. At the American Association for Cancer Research meeting on Sunday ...
Investors Business Daily · ByAmy Reeves · 4/7/2014
Merial competes head to head with Pfizer’s former animal health business Zoetis (ZTS.N), which Brandicourt helped to list on the New York Stock Exchange in a previous job at Pfizer (PFE.N) in 2013. Zoetis, with a market capitalization of $23.4 billion ... · 11/27/2015
The drugmaker Allergan, the favored stock of hedge funds, has confirmed that it has been approached by Pfizer about possibly merging to form the world's biggest pharma company. Allergan's stock is up on the news. The share price was most recently up …
The Business Insider · ByJulia La Roche · 10/29/2015
Pfizer Inc. and Allergan Plc are considering a merger ... off-patent medicines and a separate one with higher-growth brand name drugs. While Allergan stock is up about 12 percent this year, its last closing price of $287.20 is well below its July peak ...
Bloomberg · 10/29/2015
The DJIA stock posting the largest daily percentage loss ahead of the close Thursday was Pfizer Inc. (NYSE: PFE) which traded down 2.31% at $34.63. The stock’s 52-week range is $92.00 to $134.54. Volume is more than double the daily average of 27.2 ...
24/7 Wall ST · 10/29/2015
Stocks of both companies have performed well on the New York Stock Exchange this year. While Pfizer’s shares have risen nearly 13 percent year-to-date, Allergan has gained 10.6 percent.
International Business Times · 10/29/2015
Pfizer (PFE.N) was down 1.5 percent after Reuters reported ... news alerts, personal finance, stock market, and mutual funds information available on, video, mobile, and interactive television platforms.
Reuters · ByAbhiram Nandakumar · 11/19/2015
Fed minutes


Pfizer Inc. is an American multinational pharmaceutical corporation headquartered in New York City, with its research headquarters in …
Pfizer Inc. is an American multinational pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut. It is among the world's largest pharmaceutical companies. Pfizer is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004.
Data from: Wikipedia